Press Releases Year All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Mar 03, 2021 TCR² Therapeutics to Participate in Two Upcoming Conferences in March Feb 17, 2021 TCR² Therapeutics to Present at SVB Leerink Global Healthcare Conference Feb 04, 2021 TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors Jan 19, 2021 TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock Jan 19, 2021 TCR² Therapeutics Announces Proposed Public Offering of Common Stock Jan 08, 2021 TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones
